Related Experiment Video
Updated: Jul 18, 2026

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
Drotrecogin alfa (activated) for nonmenstrual toxic shock syndrome associated with methicillin resistant
Dafer W Haddadin1, Imran Q Samnani, Jonathan P Moorman
1Department of Internal Medicine, Division of Infectious Diseases, East Tennessee State University, Box 70622, Johnson City, TN 37614, USA. alhaddad@mail.etsu.edu
Abstract:
Nonmenstrual toxic shock syndrome (TSS) due to Staphylococcus aureus can lead to significant morbidity and mortality. While drotrecogin alfa (DA) has been employed in patients with Methicillin-resistant Staphylococcus aureus (MRSA) severe sepsis and septic shock, its utility in TSS remains unclear. The authors report a case of severe sepsis in the setting of MRSA-associated TSS that responded to treatment with DA. This case illustrates a potential role for DA in the treatment of toxic shock syndromes and emphasizes the importance of aggressive diagnostic and therapeutic modalities in approaching these conditions.
Related Concept Videos
Diphtheria
Rheumatic Heart Disease III: Medical Management
Clinical Significance of Antibiotic Resistance
Continuous Renal Replacement Therapy
Staphylococcal Skin Infections
Drug Toxicity: Allergic Reactions
